Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approachSengül Tozlu, Ivan Bièche, Igor Girault et al.|Endocrine Related Cancer|2006Cited by 239
mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene‐expression levelsSandra E. Ghayad, Pascale A. Cohen, Ivan Bièche et al.|Cancer Science|2008Cited by 76
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancerSandra E. Ghayad, Pascale A. Cohen, Ivan Bièche et al.|Journal of Molecular Endocrinology|2008Cited by 70
Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell linesJulie A. Vendrell, Pascale A. Cohen, Ivan Bièche et al.|Endocrine Related Cancer|2005Cited by 45
Oligonucleotide microarray analysis of estrogen receptor α-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifenSengül Tozlu-Kara, Ivan Bièche, V. Roux et al.|Journal of Molecular Endocrinology|2007Cited by 33